I. E. Secinti Et Al. , "PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition," American Journal of Clinical Pathology , vol.158, no.4, pp.506-515, 2022
Secinti, I. E. Et Al. 2022. PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition. American Journal of Clinical Pathology , vol.158, no.4 , 506-515.
Secinti, I. E., ÖZGÜR, T., & Dede, I., (2022). PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition. American Journal of Clinical Pathology , vol.158, no.4, 506-515.
Secinti, Ilke, TÜMAY ÖZGÜR, And Isa Dede. "PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition," American Journal of Clinical Pathology , vol.158, no.4, 506-515, 2022
Secinti, Ilke E. Et Al. "PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition." American Journal of Clinical Pathology , vol.158, no.4, pp.506-515, 2022
Secinti, I. E. ÖZGÜR, T. And Dede, I. (2022) . "PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition." American Journal of Clinical Pathology , vol.158, no.4, pp.506-515.
@article{article, author={Ilke Evrim Secinti Et Al. }, title={PD-L1 Expression in Colorectal Adenocarcinoma Is Associated with the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition}, journal={American Journal of Clinical Pathology}, year=2022, pages={506-515} }